Every payment is final. Its refund policy allows a refund only if a provider medically disqualifies you, minus the cost of services already provided, and a multi-month plan is non-refundable "in whole and in part."
The "Starting at" price on each GLP-1 page is the 12-month plan, billed $948 (semaglutide) or $1,548 (tirzepatide) up front, and the product page doesn't say so. The checkout also shows an "Original price" of $507 for one month of semaglutide, cut to $139 by an automatically applied holiday code.
Each GLP-1 has a cheaper twin listing ($89 semaglutide, $109 tirzepatide) with an identical page and a separate "Special" intake, and no stated condition. Its vials are "designed to cover 28 days" while prices are quoted per month.
Two things compound here. The advertised figures are prepay rates, so the month-to-month price is 16% higher on semaglutide than the homepage suggests. And the cycle is 28 days while the page says "per month" — its intake's one-month card says "billed every 28 days" and "A 4-week supply each time". Thirteen charges at $87 is $1,131 a year, not the $1,044 a monthly reading implies.
$99/mo (3-month protocol)
advertised
The month is an installment on a course. Bayan's Terms state that certain protocols ship two or three months of medication in a single delivery while payment is collected in monthly installments, and that by ordering you agree your payment obligation covers the entire protocol dispensed to you regardless of the timing of those charges. Stopping in month two of a ninety-day protocol does not stop the bill, and the refund policy adds that patients who discontinue early are not entitled to a prorated refund.
Semaglutide injection starts at $199 a month — the only price on the site with "/mo" beside it. Tirzepatide starts at $399, with no billing interval stated. Every figure is a floor; the price after the intake, and whether it changes with dose, is not published.
The three-month plan is preselected, so the button reads "Get Started — $558 for 3 months" until you pick 1 Month. The same tirzepatide page also shows a comparison table at "$299/mo" and a brand-price box at "$199 per month, all-inclusive"; the semaglutide page says "$199/mo" in the same spots. Go by the plan picker.
Auto-refill enrollment. Each "Save" badge implies a higher price for a single order, but that price is not published anywhere on the product pages.
$119/mo (3-mo supply)
advertised
The "from $179" and "from $109" GLP-1 figures on its homepage and product pages are 12-month supply rates. Month to month, tirzepatide is $249 and semaglutide $199.
The headline GLP-1 prices are first-term rates: the monthly plan rises after month one, and the 3- and 6-month plans rise after their first term. A first-order "welcome credit" ($180 semaglutide, $300 tirzepatide) applies once. Its peptide prices are "from" figures; on its anti-aging bundle, the "from" price is the quarterly plan's monthly cost, not the monthly plan.
Nova publishes more than one price for the same product and never reconciles them. The semaglutide page leads with $152 while its own FAQ underneath asks what "the $229/mo" includes and answers with $50 of membership plus medication from $130, which is $180; tirzepatide does the same at $167 against "$279" and $50 plus $180. The oral daily doses are worse: the hero says $127, while the FAQ prices the semaglutide tablets at $25 a month on top of the $50 membership and says its 90-day tier "comes out to $116/mo all-in". There is no way to tell from the outside which figure a card will actually be charged.
$125/mo (longer plan)
advertised
Every headline is the longest plan's rate, captioned "Your price depends on plan length." If you leave a multi-month plan early, the months you received are re-rated at the shortest plan covering them and the difference is charged at cancellation.
The low GLP-1 figures belong to the three-month pack, paid up front; month to month is $30 more. Both are a fall offer valid only in the 38 states plus DC listed on its page, and patients already taking a GLP-1 or transferring a prescription are told to contact support for pricing.
$129–$189/mo by dose
advertised
"Per month" on every price table, "Billed every 28 days" at the GLP-1 checkout. The per-day claims on its peptide pages hold only on longer plans, or not at all: sermorelin at $129 is "Less than $4/day," which a 28-day month puts at about $4.61.
$399 / 3 mo (about $133/mo) (3-month minimum)
advertised
The site carries more than one price for the same thing. Its FAQ says the GLP-1 program starts at $183 a month, against $120 on the semaglutide page. Its glutathione page prints "$349 total" on the plan card and "The three-month plan is priced at $267" in the terms beneath it. And its tirzepatide page offers a month-to-month plan directly above a renewal line saying the plan "Automatically renews every 3 months". The figures shown here are the plan cards, the surface a buyer clicks.
The $299 struck through beside $189 is never explained, and the page says the real price depends on a subscription plan it does not show. Its homepage says pricing is "tiered" by dose, but no dose tier is printed.
$349 / 11 wks (about $138/mo)
advertised
Every "$X/month" headline divides an 11-week charge by three calendar months, so each understates the real monthly cost by about a fifth — and there is no monthly plan to buy.
The headline is the twelve-month plan presented as a monthly rate. Pick the one-month tab and the same semaglutide is $159.
From $267 / 8 wks (about $145/mo)
advertised
"Monthly installments" split the same package price into payments; they are not a monthly plan. Its new-patient guide prices semaglutide at $499 for 12 weeks while the product page says $495, and some pharmacies cost more (tirzepatide through Miller's of Wycoff is $867 for 12 weeks).
The hero figure is the 12-month plan, paid upfront: $1,668 a year for tirzepatide, $1,068 for semaglutide, $1,188 for sermorelin. And every tier sits beside a crossed-out price — $339 for tirzepatide, $249 for semaglutide, $229 for sermorelin and NAD+, $145 for glutathione — with a "SAVE" amount worked out from it ($2,400 a year on tirzepatide). No plan on its pages sells at those crossed-out prices.